Breaking News Instant updates and real-time market news.

MDT

Medtronic

$90.66

-3.02 (-3.22%)

12:35
11/19/18
11/19
12:35
11/19/18
12:35

Medtronic put volume heavy and directionally bearish

Bearish flow noted in Medtronic with 5,884 puts trading, or 4x expected. Most active are 11/23 weekly 88.5 puts and Dec-18 87.5 puts, with total volume in those strikes near 3,000 contracts. The Put/Call Ratio is 1.77, while ATM IV is up over 4 points on the day. Earnings are expected on November 20th.

  • 20

    Nov

  • 03

    Dec

MDT Medtronic
$90.66

-3.02 (-3.22%)

10/16/18
LEHM
10/16/18
INITIATION
LEHM
Barclays starts MedTech sector with Positive view
Barclays analyst Kristen Stewart last night initiated coverage of the MedTech sector with a Positive view. The analyst expects the MedTech market to grow 4%-5% "for the foreseeable future" and believes the recent increase in price-to-earnings multiples in the space is warranted given the improving fundamentals. Looking ahead, she thinks relative P/E multiples "should be at least maintained." Stewart initiated coverage on 12 stocks, with Overweight ratings on Abbott (ABT), Boston Scientific (BSX) Stryker (SYK) and Medtronic (MDT). The analyst put Underweight ratings on Baxter (BAX), Edwards Lifesciences (EW) and Zimmer Biomet (ZBH).
10/16/18
10/16/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Abbott (ABT), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT) were initiated with an Overweight at Barclays, while Baxter (BAX), Edwards Lifesciences (EW), and Zimmer Biomet (ZBH) were initiated with an Underweight. 2. Expedia (EXPE) was initiated with an Outperform at Evercore ISI, while TripAdvisor (TRIP) was initiated with an In Line, and Booking Holdings (BKNG) was initiated with an In Line. 3. Facebook (FB) was initiated with a Buy at Loop Capital and Rosenblatt. 4. Snap (SNAP) initiated with a Hold at Loop Capital. 5. VF Corp. (VFC) initiated with a Neutral at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/05/18
PIPR
11/05/18
NO CHANGE
PIPR
Overweight
Globus Medical unlikely to be hurt by Medtronic approval, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien noted that Medtronic (MDT) and Mazor Robotics (MZOR) received FDA 510K approval late last week for their new Mazor X Stealth system. He believes that Medtronic is closing the technology gap with Globus Medical (GMED) with the Mazor X Stealth, but he still sees the latter in the lead and thinks new features that Globus intends to introduce this year will keep it there. O'Brien has Overweight ratings on both Globus Medical and Medtronic.
11/06/18
STFL
11/06/18
NO CHANGE
Target $70
STFL
Buy
Stifel still upbeat on IntriCon's long-term prospects after Q3 report
Stifel analyst Jonathan Block said IntriCon's (IIN) stock might see some selling pressure after the company's Q3 revenue of $30.1M came in modestly below his $30.5M forecast, but he remains upbeat on the company's long-term prospects given his view that it is still very early in the process of IntriCon benefiting from Medtronic's (MDT) 670G/690G product cycles. Block keeps a Buy rating and $70 price target on shares of IntriCon, which are down $9.77, or 22%, to $34.52 in morning trading.

TODAY'S FREE FLY STORIES

PREKF

PrairieSky Royalty

$0.00

(0.00%)

06:39
04/22/19
04/22
06:39
04/22/19
06:39
Conference/Events
PrairieSky Royalty management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

KRA

Kraton

$36.45

0.03 (0.08%)

06:35
04/22/19
04/22
06:35
04/22/19
06:35
Hot Stocks
Kraton appoints Atanas Atanasov as CFO »

Kraton announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 22

    May

LLY

Eli Lilly

$115.20

-1.23 (-1.06%)

06:34
04/22/19
04/22
06:34
04/22/19
06:34
Hot Stocks
Eli Lilly announces licensing, research collaboration with Avidity »

Eli Lilly announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 04

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

NGD

New Gold

$0.86

-0.0141 (-1.61%)

06:34
04/22/19
04/22
06:34
04/22/19
06:34
Conference/Events
New Gold management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

UBER

Uber

$0.00

(0.00%)

, LYFT

Lyft

$58.31

-1.11 (-1.87%)

06:32
04/22/19
04/22
06:32
04/22/19
06:32
Periodicals
Uber, Lyft IPOs could cause higher fares, WSJ reports »

The initial public…

UBER

Uber

$0.00

(0.00%)

LYFT

Lyft

$58.31

-1.11 (-1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ONB

Old National Bancorp

$16.85

-0.28 (-1.63%)

06:32
04/22/19
04/22
06:32
04/22/19
06:32
Earnings
Old National Bancorp reports Q1 adjusted EPS 33c, consensus 31c »

Reports Q1 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 02

    May

OKE

Oneok

$69.13

-0.59 (-0.85%)

06:30
04/22/19
04/22
06:30
04/22/19
06:30
Downgrade
Oneok rating change  »

Oneok downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

CYAD

Celyad

$21.48

(0.00%)

06:29
04/22/19
04/22
06:29
04/22/19
06:29
Conference/Events
Celyad management to meet with »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 05

    Jun

JPM

JPMorgan

$113.43

-0.86 (-0.75%)

, BTC

Bitcoin

$0.00

(0.00%)

06:26
04/22/19
04/22
06:26
04/22/19
06:26
Periodicals
JPMorgan to expand use of blockchain system to validate payments, FT says »

JPMorgan Chase plans to…

JPM

JPMorgan

$113.43

-0.86 (-0.75%)

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 21

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 16

    Jul

OKE

Oneok

$69.13

-0.59 (-0.85%)

06:26
04/22/19
04/22
06:26
04/22/19
06:26
Downgrade
Oneok rating change  »

Oneok downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

DTIL

Precision BioSciences

$12.15

-0.84 (-6.47%)

06:23
04/22/19
04/22
06:23
04/22/19
06:23
Initiation
Precision BioSciences initiated  »

Precision BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$64.18

0.16 (0.25%)

, CVX

Chevron

$119.87

-0.38 (-0.32%)

06:20
04/22/19
04/22
06:20
04/22/19
06:20
Downgrade
Anadarko, Chevron rating change  »

Anadarko downgraded to…

APC

Anadarko

$64.18

0.16 (0.25%)

CVX

Chevron

$119.87

-0.38 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    Apr

  • 14

    May

  • 22

    May

RTRX

Retrophin

$20.07

-0.13 (-0.64%)

06:18
04/22/19
04/22
06:18
04/22/19
06:18
Initiation
Retrophin initiated  »

Retrophin initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 08

    May

  • 05

    Jun

  • 30

    Jun

MU

Micron

$43.42

0.26 (0.60%)

06:18
04/22/19
04/22
06:18
04/22/19
06:18
Conference/Events
Micron management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

DTIL

Precision BioSciences

$12.15

-0.84 (-6.47%)

06:18
04/22/19
04/22
06:18
04/22/19
06:18
Initiation
Precision BioSciences initiated  »

Precision BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTRE

Watford Holdings

$28.24

0.5 (1.80%)

06:17
04/22/19
04/22
06:17
04/22/19
06:17
Initiation
Watford Holdings initiated  »

Watford Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$21.35

0.07 (0.33%)

06:15
04/22/19
04/22
06:15
04/22/19
06:15
Upgrade
Rent-A-Center rating change  »

Rent-A-Center upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENGIY

Engie SA

$0.00

(0.00%)

, EME

Emcor

$79.55

2.64 (3.43%)

06:15
04/22/19
04/22
06:15
04/22/19
06:15
Periodicals
France's Engie mulls takeover of Emcor, Bloomberg reports »

French energy firm Engie…

ENGIY

Engie SA

$0.00

(0.00%)

EME

Emcor

$79.55

2.64 (3.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAL

Caleres

$27.55

0.425 (1.57%)

06:14
04/22/19
04/22
06:14
04/22/19
06:14
Upgrade
Caleres rating change  »

Caleres upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOV

Dover

$97.93

1.12 (1.16%)

06:14
04/22/19
04/22
06:14
04/22/19
06:14
Downgrade
Dover rating change  »

Dover downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

TEVA

Teva

$14.36

0.14 (0.98%)

06:13
04/22/19
04/22
06:13
04/22/19
06:13
Hot Stocks
Teva receives FDA approval to market generic nasal spray for opioid overdoses »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 04

    May

RCI

Rogers Communications

$51.39

-1.76 (-3.31%)

06:13
04/22/19
04/22
06:13
04/22/19
06:13
Downgrade
Rogers Communications rating change  »

Rogers Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 23

    May

TEVA

Teva

$14.36

0.14 (0.98%)

06:10
04/22/19
04/22
06:10
04/22/19
06:10
Hot Stocks
Teva receives FDA approval to market generic nasal spray for opioid overdoses »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 04

    May

CAL

Caleres

$27.55

0.425 (1.57%)

06:09
04/22/19
04/22
06:09
04/22/19
06:09
Upgrade
Caleres rating change  »

Caleres upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBK

Triumph Bancorp

$29.38

-1.37 (-4.46%)

06:08
04/22/19
04/22
06:08
04/22/19
06:08
Downgrade
Triumph Bancorp rating change  »

Triumph Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 01

    May

  • 16

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.